Skip to main content


11 Drugs That Cause Arthritis

Sep 23, 2021

This is the #1 question I get from new consults: “How did I get arthritis?”

But as aching patients ask this question, they are really thinking these joint complaints must be due to something.

Read Article
Interested in becoming a rheumatologist? It’s interview season! Dr. Kathryn Dao (@KDAO2011 ) shares tips for the interviewer AND the candidate. #RheumNow #RheumTwitter
Dr. John Cush @RheumNow( View Tweet )
Sep 21, 2021
Have an interest in following healthcare trends and updates on Twitter? Dr. Rachel Tate ( @uptoTate ) shared the top three healthcare hashtags to follow. #RheumNow
Dr. John Cush @RheumNow( View Tweet )
Sep 15, 2021

FDA Review of Vaping Products Extended

Sep 09, 2021

The FDA has again extended its decision on whether the manufacturers of vaping products can market their e-cigarettes in the United States.

Previously, the manufacturers (Juul, Vuse and Blu) were given until September 2020 to submit data to the FDA on the use and safety of these

Read Article
ICYMI: The Greatest Rheumatologist - Part II #RheumNow
Dr. John Cush @RheumNow( View Tweet )
Sep 07, 2021

ICYMI: The Greatest Rheumatologist - Part II

Sep 06, 2021

Wow! I hope you read part I of yesterday's “Greatest Rheumatologist” article.  So many big names and yet, other names and stories that were equally inspirational.

If you read the comments of the part I article you can clearly see several themes emerge.

Read Article

ICYMI: The Greatest Rheumatologist - Part I

Sep 06, 2021

Who is the greatest rheumatologist? What makes for a great rheum? Is it clinical acumen, scientific achievement, educational prowess or years of unrivaled service or mentoring? Rheumatologists are quite opinionated on this subject and very nostalgic about their mentors and leaders. When I’ve

Read Article

Expert Panel: Initial Views on FDA Warnings for JAK Inhibitors

Sep 02, 2021

Dr. Jack Cush is joined by Drs. Roy Fleischmann (Dallas), Allan Gibofsky (NYC), and Artie Kavanaugh (San Diego) to discuss the 9/2/21 FDA Drug Safety Communication regarding the cardiovascular and cancer risks arising from the Pfizer 1133 (ORAL Surveillance) tofacitinib study, but also applied

Read Article

Rare Risks Associated with BNT162b2 mRNA Covid-19 Vaccine

Aug 26, 2021

The current NEJM reports that the use of the Pfizer mRNA vaccine (BNT162b2) demonstrated a very low risk for certain serious adverse events, including the risk of myocarditis (1 to 5 events per 100,000 persons). 

The paper examines the safety of the BNT162b2 mRNA vaccine and a broad

Read Article

The Predictive Value of Morning Stiffness

Aug 25, 2021

A prospective study evaluated the value and associations with morning stiffness in patients with clinically suspect arthralgia, and found that the presence of morning stiffness increases the odds of inflammation (as detected by CRP and MRI synovitis).

Read Article

FDA Approves First COVID-19 Vaccine

Aug 23, 2021

Today, the U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine, manufactured by Pfizer-BioNTech COVID-19 the vaccine, now marketed as Comirnaty (koe-mir’-na-tee), is approved for the prevention of COVID-19 disease in individuals 16 years of age and older.


Read Article

Passive Smoke Exposure and Rheumatoid Risk

Aug 23, 2021

A current report in Arthritis & Rheumatology examined the Nurses Health Study II data set and shows that parental smoking, and passive exposure to children, can later lead to an increased risk of adult-onset incident seropositive rheumatoid arthritis (RA).

Read Article

HHS, FDA & CDC Joint Recommendation on COVID Booster

Aug 19, 2021

Today, public health and medical experts from the U.S. Department of Health and Human Services (HHS) released the following statement on the Administration’s plan for COVID-19 booster shots for the American people.

Read Article
Here is a fairly obvious piece of advice: If a patient presents with a diagnosis (self-made) rather than a symptom, work hard to clarify the symptom itself. You usually make the same diagnosis but not always...

Adam Cifu @adamcifu( View Tweet )

Aug 17, 2021

What Factors Predict RA in First-Degree Relatives?

MedPage Today
Aug 16, 2021

Among a cohort of first-degree relatives of patients with rheumatoid arthritis (RA), certain patient characteristics, as well as symptoms, helped predict a possible increased risk for developing the disease, U.K. researchers reported.

In a group of 870 first-degree relatives, 13.3%

Read Article

Booster Shots for Rheumatology Patients on Immunosuppressive Medications

ACR Press Release
Aug 16, 2021

ATLANTA – The CDC's Advisory Committee on Immunization Practices today recommended that rheumatology patients being actively treated with high-dose corticosteroids, alkylating agents, antimetabolites, TNF blockers, and other biologic agents that are immunosuppressive or immunomodulatory receive

Read Article

Fibromyalgianess Influences Steroid Persistence

Jul 30, 2021

"Fibromyalgianess" is highlighted as a risk factor for undue, extended glucocorticoid use in rheumatoid arthritis (RA) patients, according to Wallace and colleagues in Rheumatology.

Fibromyalgianess is associated more disability and poor responses to RA treatment and can be

Read Article

Cardiovascular Prevention Lacking in Rheumatoid Arthritis

Jul 28, 2021

An increased cardiovascular disease (CVD) risk in rheumatoid arthritis is well known and feared but an RA cohort study suggests that preventive medication use in RA patients lags behind that seen in diabetes mellitus (DM).

Read Article

CDC Reverses Stance on Masks

Jul 27, 2021

Today the Centers for Disease Control and Prevention (CDC) said that masks should be used by those vaccinated against the coronavirus in public indoor spaces in parts of the country where the virus is surging.

They also recommended universal masking for teachers, staff, students and

Read Article

Fracture Risk with Low Dose Steroid

Jul 22, 2021

A large RA cohort analysis shows that low-dose glucocorticoid therapy in rheumatoid arthritis (RA) patients may carry an increased risk of vertebral osteoporotic (OP) fractures. 

There were 15,123 RA patients (mean age 68.8 years) enrolled in Clinical Practice Research Datalink

Read Article

Arthritis as a Harbinger of Pediatric Cancer

Jul 15, 2021

Lancet Rheumatology has published a cohort analysis showing that a small but significant subset of children presenting with arthralgia or arthritis may have a pediatric malignancy.

This multicentre study sought to identify articular presentations of children manifesting

Read Article

ICYMI: 2020 Rheumatology Year in Review

Jul 08, 2021

2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related. Below, are our top news items

Read Article
Textbooks say fever is common in lupus ("36%–86%") BUT IT IS NOT! Lupus is cause of FUO in 5%; Fever is seen in a minority of SLE onsets; Fever occurs w/ SLE complications - vasculitis, pneumonitis/serositis/alveolar hem, CNS, & INFECTION!

Dr. John Cush @RheumNow( View Tweet )

Jul 07, 2021

ICYMI: EULAR Guidelines on Intraarticular Therapy

Jul 07, 2021

EULAR has published evidence-based recommendations on the use of intra-articular therapies (IAT) based on the literature review and recommendations of a multidisciplinary international task force. These IAT recommendations apply to adult patients with peripheral arthropathies.


Read Article

ICYMI: Rheumatologists Rank 2nd in Physician Burnout

Jul 06, 2021

The 2021 Medscape Survey on Physician burnout ranks rheumatology second, just behind Critical Care medicine.

The survey included over 12,000 physcians from 20 specialties. While 42% of MDs claimed to be burnt-out, Rheumatologists claimed this 50% of the time. The top 3 this year were Critical

Read Article